|
Volumn 13, Issue 2, 2006, Pages 121-126
|
Treatment of mild to moderate psoriasis with Reliéva, a Mahonia aquifolium extract - A double-blind, placebo-controlled study
|
Author keywords
Clinical trial; Efficacy; Mahonia aquifolium; Psoriasis; Safety
|
Indexed keywords
ANTIPSORIASIS AGENT;
MAHONIA AQUIFOLIUM EXTRACT;
PLACEBO;
PLANT EXTRACT;
PSORBERINE;
RELIEVA;
UNCLASSIFIED DRUG;
DERMATOLOGICAL AGENT;
ADULT;
APPLICATION SITE BURNING;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREAM;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
EMULSION;
FEMALE;
HOMEOPATHY;
HUMAN;
MAHONIA;
MAHONIA AQUIFOLIUM;
MAJOR CLINICAL STUDY;
MALE;
MEDICINAL PLANT;
PRIORITY JOURNAL;
PSORIASIS;
PSORIASIS AREA SEVERITY INDEX;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SKIN DISEASE;
TRADITIONAL MEDICINE;
TREATMENT OUTCOME;
AGED;
CHEMISTRY;
MIDDLE AGED;
PATHOLOGY;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
ADULT;
AGED;
AGED, 80 AND OVER;
DERMATOLOGIC AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MAHONIA;
MALE;
MIDDLE AGED;
PLANT EXTRACTS;
PSORIASIS;
|
EID: 33646591516
PISSN: 10752765
EISSN: None
Source Type: Journal
DOI: 10.1097/00045391-200603000-00007 Document Type: Article |
Times cited : (53)
|
References (11)
|